Bayesian Capital Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-17,314
Closed -$157K 823
2018
Q1
$157K Buy
+17,314
New +$157K 0.04% 522